Unlocking the Therapeutic Synergy of Nitric Oxide (NO) and Chlorambucil (Cbl) via Photoresponsive Sequential Delivery in a Triple-Negative Breast Cancer 3D Spheroidal Platform with Transcriptomic Insights
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c01995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Venkatesh Sarampally und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Natural Products and Medicinal Chemistry, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India. Hauptthemen laut MEDLINE: Chlorambucil, Triple Negative Breast Neoplasms, Nitric Oxide, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Indian Council of Medical Research, Science and Engineering Research Board, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Nitric oxide (NO) is a multifunctional signaling molecule in oncology, influencing tumor progression, apoptosis, and immune responses. In contrast, chlorambucil (Cbl), a DNA-alkylating chemotherapeutic, induces cytotoxicity through DNA damage. Here, we report a photoresponsive nanoparticle platform for sequential codelivery of NO and Cbl, where NO is released within 10 min of irradiation, followed by Cbl release within 30 min. The nanoplatform employs a coumarin-4-ylmethyl photoremovable protecting group (PRPG) to achieve light-triggered spatiotemporal release of both agents. Using 2D cultures and 3D triple-negative breast cancer (TNBC) spheroids, we observed that NO-assisted chemotherapy markedly improved tumor inhibition and apoptosis compared to Cbl alone. Transcriptomic profiling (RNA-seq) revealed modulation of oncogenic pathways (PI3K/AKT, NF-κB, MAPK, EMT) with upregulation of tumor suppressors (TP53, CASP10, TIMP1) and downregulation of oncogenes (BCL2, MMP9, VEGFC). Additionally, suppression of IL-6, TNF-α, and ECM remodeling factors indicated reduced metastatic potential. This strategy highlights NO-mediated synergy as a promising approach to overcome chemoresistance in TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Natural Products and Medicinal Chemistry, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India.
- Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, Uttar Pradesh, India.
- Department of Organic Synthesis and Process Chemistry, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India.
ORCID-Profile: Venkatesh Sarampally, Ajay K Singh, Avijit Jana
Förderung
- Indian Council of Medical Research
- Science and Engineering Research Board
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Sarampally, V., Poddar, S., Trivedi, P., Rana, A., Singh, A. K., Chandra Shekar, K., Saha, B., & Jana, A. (2025). Unlocking the Therapeutic Synergy of Nitric Oxide (NO) and Chlorambucil (Cbl) via Photoresponsive Sequential Delivery in a Triple-Negative Breast Cancer 3D Spheroidal Platform with Transcriptomic Insights. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c01995
Vancouver
Sarampally V, Poddar S, Trivedi P, Rana A, Singh AK, Chandra Shekar K, et al. Unlocking the Therapeutic Synergy of Nitric Oxide (NO) and Chlorambucil (Cbl) via Photoresponsive Sequential Delivery in a Triple-Negative Breast Cancer 3D Spheroidal Platform with Transcriptomic Insights. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c01995
BibTeX
@article{Sarampally2025,
author = {Sarampally, Venkatesh and Poddar, Soumyadeep and Trivedi, Pragya and Rana, Abhilash and Singh, Ajay K and Chandra Shekar, Kunta and Saha, Biswajit and Jana, Avijit},
title = {Unlocking the Therapeutic Synergy of Nitric Oxide (NO) and Chlorambucil (Cbl) via Photoresponsive Sequential Delivery in a Triple-Negative Breast Cancer 3D Spheroidal Platform with Transcriptomic Insights},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c01995}
}
EUVIMED